A new study examining the gene phosphate and tensin homolog (PTEN) calls for both early detection of cancer and awareness of the importance of precision therapy.
Studying the role of CSCs in cancers of the brain, colon, rectum, breast, lung, bone marrow and more may one day help develop new treatments. A look at our new Center for Cancer Stem Cell Research, led by Shideng Bao, PhD.
From patient-staff models to placing electrical outlets, nurses were part of the team making decisions for the new cancer center. Learn more about how it worked.
By now most rheumatologists are aware that checkpoint inhibitors are capable of unleashing a wide array of autoimmune and autoinflammatory adverse events within virtually every organ system. These complications have posed new challenges to all practitioners.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic began offering shared medical appointments for early stage post-extraction melanoma patients in August hoping to change self-care behaviors and prevent recurrence of the disease.
Primary care physicians play a vital role in detecting cancers at earlier stages. Referrals for colonoscopy have a significant impact on early detection rates for colorectal cancer.
Cleveland Clinic research findings suggest that effective steroidal antiandrogens share common metabolic activities and metabolites should be closely examined for effects on tumor survival.
As volume-based experience continues to yield outcome dividends for patients needing esophagectomy, thoracic surgeons are increasingly turning to robotics to minimize the procedure’s invasiveness.
With time to treat rising nationally, Cleveland Clinic is seeing reductions. How? Get the answer from Digestive Disease & Surgery Institute Chairman Conor Delaney, MD, PhD, in our “The Short Answer” series.
New evidence shows that men on active surveillance of prostate cancer can safely wait at least five years between surveillance biopsies. Study authors hope new findings increase appeal of disease monitoring and reduce patient and provider anxiety.